Top compounds associated with response to DRD5


Feature Type Standardized
Nominal ANOVA
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.081 0.02
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.02
mRNA Rapamycin gCSI pan-cancer AAC -0.12 0.02
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.069 0.03
mRNA temsirolimus FIMM pan-cancer AAC 0.35 0.03
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.07 0.03
mRNA FH535 GDSC1000 pan-cancer AAC -0.073 0.03
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.11 0.03
mRNA A-804598 CTRPv2 pan-cancer AAC 0.1 0.03
Download CSV